{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:24:44Z","timestamp":1772803484806,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":8431,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1017\/s1041610201007876","type":"journal-article","created":{"date-parts":[[2004,3,10]],"date-time":"2004-03-10T12:08:43Z","timestamp":1078920523000},"page":"461-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Butyrylcholinesterase and Cognitive Function"],"prefix":"10.1016","volume":"13","author":[{"given":"Sultan","family":"Darvesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"MacKnight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Rockwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610201007876_bb0010","first-page":"147","article-title":"Ethopropazine and benztropine in neuroleptic- induced parkinsonism","volume":"40","author":"Chouinard","year":"1979","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610201007876_bb0015","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/(SICI)1096-9861(19980413)393:3<374::AID-CNE8>3.0.CO;2-Z","article-title":"Butyrylcholinesterase in normal human amygdala and hippocampal formation","volume":"393","author":"Darvesh","year":"1998","journal-title":"Journal of Comparative Neurology"},{"key":"10.1017\/S1041610201007876_bb0020","first-page":"201","article-title":"Distribution of butyrylcholinesterase in normal human forebrain","volume":"22","author":"Darvesh","year":"1996","journal-title":"Neuroscience Abstracts"},{"key":"10.1017\/S1041610201007876_bb0025","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1017\/S0317167100038051","article-title":"Systemic therapy of dystonia","volume":"14","author":"Fahn","year":"1987","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"10.1017\/S1041610201007876_bb0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer\u2019s disease: A review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1017\/S1041610201007876_bb0035","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.2042-7158.1998.tb03349.x","article-title":"Anti-nicotinic properties of anticholinergic antiparkinson drugs","volume":"50","author":"Gao","year":"1998","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1017\/S1041610201007876_bb0040","series-title":"Cholinesterases and cholinesterase inhibitors","first-page":"181","article-title":"Cholinesterase inhibitors: From calabar bean to Alzheimer therapy","author":"Giacobini","year":"2000"},{"key":"10.1017\/S1041610201007876_bb0045","first-page":"728","article-title":"Novel, selective butyrylcholinesterase (BuChE) inhibitors for the treatment of Alzheimer\u2019s disease (AD)","volume":"24","author":"Greig","year":"1998","journal-title":"Neuroscience Abstracts"},{"key":"10.1017\/S1041610201007876_bb0050","first-page":"261","article-title":"Effects of anticholinergic antiparkinsonian drugs on binding of muscarinic receptor subtypes in rat brain","volume":"69","author":"Katayama","year":"1990","journal-title":"Research Communications in Chemical Pathology and Pharmacology"},{"key":"10.1017\/S1041610201007876_bb0055","series-title":"Cholinesterases and cholinesterase inhibitors","first-page":"121","article-title":"Neuroanatomy of cholinesterases in the normal human brain and Alzheimer\u2019s disease","author":"Mesulam","year":"2000"},{"key":"10.1017\/S1041610201007876_bb0060","doi-asserted-by":"crossref","first-page":"9276","DOI":"10.1073\/pnas.150243397","article-title":"Subnucleus-specific loss of neurons in medial thalamus of schizophrenics","volume":"97","author":"Popken","year":"2000","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1017\/S1041610201007876_bb0065","series-title":"The biology of cholinesterases","author":"Silver","year":"1974"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224038572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224038572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610201007876","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T01:49:03Z","timestamp":1736473743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224038572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S1041610224038572"],"URL":"https:\/\/doi.org\/10.1017\/s1041610201007876","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Butyrylcholinesterase and Cognitive Function","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610201007876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}